These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30366367)

  • 1. VE-Albumin Core-Shell Nanoparticles for Paclitaxel Delivery to Treat MDR Breast Cancer.
    Tang B; Qian Y; Gou Y; Cheng G; Fang G
    Molecules; 2018 Oct; 23(11):. PubMed ID: 30366367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
    Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
    Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TPGS and chondroitin sulfate dual-modified lipid-albumin nanosystem for targeted delivery of chemotherapeutic agent against multidrug-resistant cancer.
    Luo K; Xu F; Yao T; Zhu J; Yu H; Wang G; Li J
    Int J Biol Macromol; 2021 Jul; 183():1270-1282. PubMed ID: 34004196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: In vitro/in vivo evaluation and binding properties investigation.
    Zhao Y; Cai C; Liu M; Zhao Y; Wu Y; Fan Z; Ding Z; Zhang H; Wang Z; Han J
    Int J Biol Macromol; 2020 Jun; 153():873-882. PubMed ID: 32169451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
    Wu J; Zhang J; Deng C; Meng F; Zhong Z
    Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart Polymeric Nanoparticles with pH-Responsive and PEG-Detachable Properties (II): Co-Delivery of Paclitaxel and VEGF siRNA for Synergistic Breast Cancer Therapy in Mice.
    Jin M; Hou Y; Quan X; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2021; 16():5479-5494. PubMed ID: 34413645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancer.
    Ma Y; Liu D; Wang D; Wang Y; Fu Q; Fallon JK; Yang X; He Z; Liu F
    Mol Pharm; 2014 Aug; 11(8):2623-30. PubMed ID: 24712391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
    Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
    Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E-based redox-sensitive salinomycin prodrug-nanosystem with paclitaxel loaded for cancer targeted and combined chemotherapy.
    Liang DS; Liu J; Peng TX; Peng H; Guo F; Zhong HJ
    Colloids Surf B Biointerfaces; 2018 Dec; 172():506-516. PubMed ID: 30212688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy.
    Ding D; Tang X; Cao X; Wu J; Yuan A; Qiao Q; Pan J; Hu Y
    AAPS PharmSciTech; 2014 Feb; 15(1):213-22. PubMed ID: 24287627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of paclitaxel and curcumin by biodegradable polymeric nanoparticles for breast cancer chemotherapy.
    Xiong K; Zhang Y; Wen Q; Luo J; Lu Y; Wu Z; Wang B; Chen Y; Zhao L; Fu S
    Int J Pharm; 2020 Nov; 589():119875. PubMed ID: 32919003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Codelivery of Paclitaxel and Everolimus at the Optimal Synergistic Ratio: A Promising Solution for the Treatment of Breast Cancer.
    Houdaihed L; Evans JC; Allen C
    Mol Pharm; 2018 Sep; 15(9):3672-3681. PubMed ID: 29863881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction-sensitive Paclitaxel Prodrug Self-assembled Nanoparticles with Tetrandrine Effectively Promote Synergistic Therapy Against Drug-sensitive and Multidrug-resistant Breast Cancer.
    Jiang M; Zhang R; Wang Y; Jing W; Liu Y; Ma Y; Sun B; Wang M; Chen P; Liu H; He Z
    Mol Pharm; 2017 Nov; 14(11):3628-3635. PubMed ID: 28895735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.
    Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W
    Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy.
    Zhao T; Chen H; Dong Y; Zhang J; Huang H; Zhu J; Zhang W
    Int J Nanomedicine; 2013; 8():1947-57. PubMed ID: 23696703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
    Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
    Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel and quercetin co-loaded functional mesoporous silica nanoparticles overcoming multidrug resistance in breast cancer.
    Liu M; Fu M; Yang X; Jia G; Shi X; Ji J; Liu X; Zhai G
    Colloids Surf B Biointerfaces; 2020 Dec; 196():111284. PubMed ID: 32771817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.